Interactions of Potential Anticancer Drug 4-chloro-6-(1H-imidazo[4,5-b]phenazine-2-yl)benzene-1,3-diol with Supercoiled and Linear Plasmid DNAs
DNA · 03.06.2026 · 6 (2) · 29
DOI: 10.3390/dna6020029 ↗Kurz gefasst
Fachartikel in der Zeitschrift DNA, online erschienen am 03.06.2026. Verfasst von Dominika Janiszek und 7 weiteren Autor:innen. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Does DNA superhelicity effect nucleic acid interactions with drugs? To test such a possibility, the interactions of the linear and superhelical forms of the pGEX-4T-2 plasmid have been investigated with a newly synthesized compound, 4-chloro-6-(1H-imidazo [4,5-b]phenazine-2-yl)benzene-1,3-diol, positively tested for the antiproliferative (cell growth-limiting) properties, important for the development of anticancer drugs.
Methods
The accumulation of the compound, and its possible reorientation (phase transition) within the plasmid layer adsorbed on a Glassy Carbon (GC) electrode has been monitored in 5 min. intervals using alternatively two voltammetric methods—Differential Pulse (DP), showing redox properties and—Alternating Current (AC), reflecting both redox and structural properties (capacity/resistance change related to DNA condensation) of the DNA-drug layers. Results and Discussion: The accumulation plots of the compound in plasmid layers are different for superhelical and linear pGEX-4T-2 and also depend on the DNA coverage by the compound. The reorientation (phase transition) occurs at a compound concentration 2 µM for the superhelical plasmid and 1.5 µM for the linear one, as compared to 8 µM for the compound layer formed on bare GC, thus proving the existence of the DNA–compound interactions. Interestingly, the phase transition is redox-sensitive, e.g., AC redox signal II is visible for the linear, but not for the superhelical plasmid, thus reflecting different orientation of the compound in these two types of pGEX-4T-2 plasmid, related to the condensation in the DNA–compound layer and seen as a decrease in the C/R signal.
Conclusions
The results suggest that the reorientation of the compound leading to plasmid condensation occurs differently in supercoiled and linear pGEX-4T-2 (redox specific accumulation and condensation).
Zitieren
APA
Janiszek, D., Banasiak, A., Karpinska, M. M., Niewiadomy, A., Girstun, A., Elzanowska, H., Maj-Zurawska, M., & Kulesza, P. J. (2026). Interactions of Potential Anticancer Drug 4-chloro-6-(1H-imidazo[4,5-b]phenazine-2-yl)benzene-1,3-diol with Supercoiled and Linear Plasmid DNAs. DNA, 6(2), 29. https://doi.org/10.3390/dna6020029
Vancouver
Janiszek D, Banasiak A, Karpinska MM, Niewiadomy A, Girstun A, Elzanowska H, et al. Interactions of Potential Anticancer Drug 4-chloro-6-(1H-imidazo[4,5-b]phenazine-2-yl)benzene-1,3-diol with Supercoiled and Linear Plasmid DNAs. DNA. 2026;6(2):29. doi:10.3390/dna6020029
BibTeX
@article{Janiszek2026,
author = {Janiszek, Dominika and Banasiak, Anna and Karpinska, Monika M. and Niewiadomy, Andrzej and Girstun, Agnieszka and Elzanowska, Hanna and Maj-Zurawska, Magdalena and Kulesza, Pawel J.},
title = {Interactions of Potential Anticancer Drug 4-chloro-6-(1H-imidazo[4,5-b]phenazine-2-yl)benzene-1,3-diol with Supercoiled and Linear Plasmid DNAs},
journal = {DNA},
year = {2026},
volume = {6},
number = {2},
pages = {29},
doi = {10.3390/dna6020029}
}
EUVIMED